Devises / CLSD
CLSD: Clearside Biomedical Inc
0.37
USD
0.02
(5.13%)
Le taux de change de CLSD a changé de -5.13% aujourd'hui. Au cours de la journée, l'instrument a été échangé à un minimum de 0.35 et à un maximum de 0.39.
Suivez la dynamique Clearside Biomedical Inc. Les cotations en temps réel vous aideront à réagir rapidement aux changements du marché. En basculant entre différentes périodes, vous pouvez surveiller les tendances et la dynamique des taux de change par minutes, heures, jours, semaines et mois. Utilisez ces informations pour prévoir les changements du marché et prendre des décisions de trading éclairées.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
CLSD Nouvelles
- Clearside Biomedical earnings beat by $0.04, revenue fell short of estimates
- Clearside Biomedical, Inc. (CLSD) Reports Q2 Loss, Beats Revenue Estimates
- Compugen (CGEN) Reports Q2 Loss, Lags Revenue Estimates
- Clearside Biomedical stock soars after Health Canada approves XIPERE
- Health Canada approves Clearside’s XIPERE for uveitic macular edema
- This Elevance Health Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday - Clearside Biomedical (NASDAQ:CLSD), Elevance Health (NYSE:ELV)
- Chardan Capital downgrades Clearside Biomedical stock rating to Neutral
- Stifel downgrades Clearside Biomedical stock to Hold on cash concerns
- Citizens JMP downgrades Clearside Biomedical stock rating as company pauses R&D
- Needham downgrades Clearside Biomedical stock to Hold on funding challenges
- Clearside Biomedical stock falls after announcing strategic alternatives exploration
- Clearside Biomedical to explore strategic alternatives amid cash concerns
- Clearside Biomedical Announces Multiple Presentations to be Featured at the Clinical Trials at the Summit Meeting
- Clearside Biomedical at Stifel Forum: Strategic Moves in Ophthalmology
- Clearside Biomedical target cut to $5 by H.C. Wainwright
- Clearside Biomedical to Participate in a Fireside Chat at the Stifel 2025 Virtual Ophthalmology Forum
- JMP maintains $5 target on Clearside Biomedical stock
- Stifel maintains Buy on Clearside Biomedical, target at $8
- Clearside Biomedical earnings missed by $0.02, revenue topped estimates
- Clearside Biomedical Announces First Quarter 2025 Financial Results and Provides Corporate Update
- Clearside Biomedical, Inc. (CLSD) Q4 2024 Earnings Conference Call Transcript
Range quotidien
0.35
0.39
Range Annuel
0.29
1.65
- Clôture Précédente
- 0.39
- Ouverture
- 0.37
- Bid
- 0.37
- Ask
- 0.67
- Plus Bas
- 0.35
- Plus Haut
- 0.39
- Volume
- 642
- Changement quotidien
- -5.13%
- Changement Mensuel
- -7.50%
- Changement à 6 Mois
- -56.98%
- Changement Annuel
- -63.37%
31 août, dimanche